Expert Review of Neurotherapeutics

Article	Citations
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease	55
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system	54
Therapeutic advances in Dravet syndrome: a targeted literature review	45
Manganese-induced neurodegenerative diseases and possible therapeutic approaches	39
Diagnosing and managing post-stroke aphasia	38
Update on diagnosis in disorders of consciousness	35
Clinical diagnosis and management of small fiber neuropathy: an update on best practice	35
The emerging role of psilocybin and MDMA in the treatment of mental illness	32
Sex differences in schizophrenia relevant to clinical care	32
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies	31
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy	29
Focal cortical dysplasia: an update on diagnosis and treatment	27
Nutrition-based interventions for mood disorders	27
Role of environmental factors in multiple sclerosis	26
Pain in cervical dystonia: mechanisms, assessment and treatment	25
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults	25
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome	23
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis	23
Clinical development of valbenazine for tics associated with Tourette syndrome	22
Emerging therapies in Friedreich’s Ataxia	22
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	22
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease	21
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges	21
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs	21
Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review	21

Motor imagery and gait control in Parkinson’s disease: techniques and new perspectives in neurorehabilitation	20
Sensory stimulation programs in dementia: a systematic review of methods and effectiveness	20
Reading mind from the eyes in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis	19
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management	19
mHealth for pediatric chronic pain: state of the art and future directions	19
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone	19
The effect of physical activity with and without cognitive demand on the improvement of executive functions and behavioral symptoms in children with ADHD	18
Efficacy and safety of greater occipital nerve block for the treatment of cluster headache: a systematic review and meta-analysis	18
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice	18
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia	17
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies	17
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis	17
Speech and language therapy in primary progressive aphasia: a critical review of current practice	17
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations	17
Acute ischemic stroke management: concepts and controversies.A narrative review	17
Combination therapy in migraine: asset or issue?	16
Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms	16
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	16
Recent advancements in tension-type headache: a narrative review	16
Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease	16
Current and emerging treatment modalities for spinocerebellar ataxias	16
Sydenham’s chorea: from pathophysiology to therapeutics	15
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis	15
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders	14
Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis	14
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	14
The efficacy of executive function interventions in children with autism spectrum disorder: a systematic review and meta-analysis	14
Is it accurate to classify ALS as a neuromuscular disorder?	14
Status epilepticus in pregnancy: a literature review and a protocol proposal	14
Considering patient age when treating multiple sclerosis across the adult lifespan	14
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group	14
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis	14
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics	14
A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders	13
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence	13
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease	13
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders	13
Real world considerations for newly approved CGRP receptor antagonists in migraine care	13
The role of a potential biomarker in patients with migraine: review and new insights	13
Considering hearing loss as a modifiable risk factor for dementia	12
Outcomes measures in idiopathic intracranial hypertension	12
Evaluating and managing severe headache in the emergency department	12
Current perspectives on exercise training in the management of multiple sclerosis	12
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy	12
The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials	11
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	11
Multidisciplinary approach to degenerative cervical myelopathy	11
What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?	11
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion	11
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia	11

Can mindfulness-based interventions benefit people with dementia? Drawing on the evidence from a systematic review in populations with cognitive impairments	11
Updated review on the link between cortical spreading depression and headache disorders	11
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting	11
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress	11
Neurotechnologies as tools for cognitive rehabilitation in stroke patients	11
Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches	11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation	11
Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review	10
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	10
Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry	10
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper	10
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome	10
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	10
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management	9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures	9
Autologous hematopoietic stem-cell transplantation in neurological disorders: current approach and future directions	9
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach	9
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review	9
Current perspectives on co-morbid depression and multiple sclerosis	9
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters	9
Suicidality and antiepileptic drugs in people with epilepsy: an update	9
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance	9
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry	9
A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes	9
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis	9
Updated perspectives on awake neurosurgery with cognitive and emotional assessment for patients with low-grade gliomas	9
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?	9
The effect of transcranial magnetic stimulation on the recovery of attention and memory impairment following stroke: a systematic review and meta-analysis	9
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis	9
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients	8
Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis	8
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	8
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review	8
Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis	8
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives	8
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis	8
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials	8
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	8
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine	8
The severity of obsessive-compulsive symptoms in Tourette syndrome and its relationship with premonitory urges: a meta-analysis	8
Gene therapy and immunotherapy as promising strategies to combat Huntington’s disease-associated neurodegeneration: emphasis on recent updates and future perspectives	7
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	7
Meniere disease subtyping: the direction of diagnosis and treatment in the future	7
‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine	7
Lasmiditan: an additional therapeutic option for the acute treatment of migraine	7
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice	7
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia	7
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	7
Tumefactive demyelination: updated perspectives on diagnosis and management	7
The efficacy of rehabilitation in people with Guillain-Barrè syndrome: a systematic review of randomized controlled trials	7
Aripiprazole for the treatment of Tourette syndrome	7
Non-pharmacological treatments for pediatric refractory epilepsies	7
Deep transcranial magnetic stimulation for obsessive compulsive disorder	7
Diagnostic challenges in metabolic myopathies	7
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?	7
Recently available and emerging therapeutic strategies for the acute and prophylactic management of cluster headache: a systematic review and expert opinion	7
Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies	6
Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of neuroprotective strategies	6
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy	6
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	6
Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies	6
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	6
A review of magnetoencephalography use in pediatric epilepsy: an update on best practice	6
Central vestibular dysfunction: don’t forget vestibular rehabilitation	6
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease	6
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	6
Pathogenesis and Management of Acute Necrotizing Encephalopathy	6
Efficacy and safety of greater occipital nerve block for the treatment of cervicogenic headache: a systematic review	6
Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts	6
Clinical applications of exercise in Parkinson’s disease: what we need to know?	6
Exercise is medicine: a new perspective for health promotion in bipolar disorder	6
Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review	6
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports	6
Novel therapeutic options for Dravet and Lennox-Gastaut syndrome	6
Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges	6
Developments in the mechanistic understanding and clinical application of deep brain stimulation for Parkinson’s disease	6
Exploring treatments for drooling in children with neurological disorders	6
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs	6
Hormonal therapies in migraine management: current perspectives on patient selection and risk management	6

Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study	6
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	6
Preventing recurrence of postpartum depression by regulating sleep	6
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	6
Do we need to reconsider the classification of vestibular migraine?	5
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	5
Polyamines serum levels in episodic and chronic migraine	5
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis	5
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	5
Exploring the role of botulinum toxin in critical care	5
Cinnarizine as an alternative recommendation for migraine prophylaxis: a narrative review	5
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	5
An update on acute and preventive treatments for migraine in children and adolescents	5
Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes	5
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development	5
Narrative review of the multisensory integration tasks used with older adults: inclusion of multisensory integration tasks into neuropsychological assessment	5
Stiripentol for the treatment of seizures associated with Dravet syndrome in patients 6 months and older and taking clobazam	5
Fibromyalgia patients should always be screened for post-traumatic stress disorder	5
Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes	5
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review	5
Long-term central nervous system (CNS) consequences of COVID-19 in children	5
An update on the pharmacotherapeutic options for complex regional pain syndrome	5
Emerging cytoprotective peptide therapies for stroke	5
Objective measurement versus clinician-based assessment for Parkinson’s disease	5
Magnetic resonance-guided focused ultrasound for the treatment of tremor	5
Treatment considerations in myasthenia gravis for the pregnant patient	5
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders	5
Treating hallucinations in Parkinson’s disease	5
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment	5
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations	5
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	5
A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavio	5
Overcoming clinical challenges of refractory neuropathic pain	5
Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine	4
Telerehabilitation in neurorehabilitation: has it passed the COVID test?	4
Tailoring the therapeutic interventions for behavioral and psychological symptoms of dementia	4
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	4
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	4
Learnings in developmental and epileptic encephalopathies: what do we know?	4
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials	4
Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: a pragmatic review	4
Neuroimaging and genetic characteristics of malformation of cortical development due to mTOR pathway dysregulation: clues for the epileptogenic lesions and indications for epilepsy surgery	4
Conventional and emerging treatments and controversies in myasthenia gravis	4
Drug profile: galcanezumab for prevention of cluster headache	4
EEG in neonatal seizures: where to look and what to see	4
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	4
Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?	4
Considerations when treating high-grade pediatric glioma patients with immunotherapy	4
Developing precision treatments for epilepsy using patient and animal models	4
Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts	4
Where Art Thou O treatment for diabetic neuropathy: the sequel	4
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	4
Current perspectives on the diagnosis and management of acute transverse myelitis	4
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	4
Postoperative pain: a review of emerging therapeutic options	4
The comorbidities of epilepsy explained	3
A novel treatment option for intrajejunal levodopa administration	3
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	3
Management of status epilepticus in patients with liver or kidney disease: a narrative review	3
Emerging role of artificial intelligence in stroke imaging	3
Insights into headache 2022	3
Lightening the mood: evidence for blue light exposure in the treatment of post-concussion depression	3
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	3
An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia	3
The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults	3
Food for thought: the emerging role of a ketogenic diet in Alzheimer’s disease management	3
Developments in combined analgesic regimens for improved safety in postoperative pain management	3
Spinal automaticity of movement control and its role in recovering function after spinal injury	3
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	3
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases	3
Updated review of rescue treatments for seizure clusters and prolonged seizures	3
Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients	3
From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)	3
Migraine and obesity: what is the real direction of their association?	3
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	3
Temporal distribution of emergency room visits in patients with migraine and other headaches	3
Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials	3
Nanomaterials in neuromodulation: what is the potential?	3
Anesthesia for electroconvulsive therapy during the COVID-19 pandemic	3